← Leaderboards
Haiying Zhang
Weill Medical Coll Of Cornell Univ
$2,021,982
Attributed
$4,183,640
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $719.8K · FY2017–25$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,183,640 · 2
By mechanism
R01$3,851,084 · 1
U19$332,556 · 1
Top collaborators
- David Charles Lyden9 shared
- Jacob Geri3 shared
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Julie Magarian Blander$17,921,173
- Shuibing Chen$16,196,697
Others in their field
Other Emerging Leaders on “Proteins”
- John Damon Chodera · Sloan-Kettering Inst Can Research$50,971,767
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Susan M Landau · University Of California Berkeley$47,252,026
- Timothy Fouts · Advanced Bioscience Laboratories, Inc.$40,723,314
- Chris Karlovich · Leidos Biomedical Research, Inc.$38,534,220
- Mathangi Thiagarajan · Leidos Biomedical Research, Inc.$37,695,154
Research focus
ProteinsBiologicalMllt2 GeneExtracellular VesiclesField Flow FractionationNanoparticleProteomicsUltracentrifugationMediatingTechnologyPlasmaPhysiciansAnalytical ToolPancreaticoduodenectomyDiagnosisComplexDetectionMalignant Neoplasm Of PancreasMedicineLiquid BiopsyExosomeMalignant NeoplasmsEnrollmentCohort
Grant awards (11)
Application of 4D proteomics and super-resolution microscopy in extracellular vesicle and particle-borne biomarker discovery for early pancreatic cancer detection$474,405
R01 · FY2025 · CA
Application of 4D proteomics and super-resolution microscopy in extracellular vesicle and particle-borne biomarker discovery for early pancreatic cancer detection$453,986
R01 · FY2024 · CA
Application of 4D proteomics and super-resolution microscopy in extracellular vesicle and particle-borne biomarker discovery for early pancreatic cancer detection$488,306
R01 · FY2023 · CA
Development and application of asymmetric-flow field-flow (AF4) technology in fractionation and characterization of exosome subpopulations and novel nanoveiscles in pancreatic cancer model$443,445
R01 · FY2021 · CA
Development and application of asymmetric-flow field-flow (AF4) technology in fractionation and characterization of exosome subpopulations and novel nanoveiscles in pancreatic cancer model$514,346
R01 · FY2020 · CA
Identification and Functional characterization of circulating exomeres in systemic lupus erythematosus$205,431
U19 · FY2020 · AI · contact PI
Development and application of asymmetric-flow field-flow (AF4) technology in fractionation and characterization of exosome subpopulations and novel nanoveiscles in pancreatic cancer model$502,765
R01 · FY2019 · CA
Identification and Functional characterization of circulating exomeres in systemic lupus erythematosus$127,125
U19 · FY2019 · AI · contact PI
Development and application of asymmetric-flow field-flow (AF4) technology in fractionation and characterization of exosome subpopulations and novel nanoveiscles in pancreatic cancer model$430,996
R01 · FY2018 · CA
Development and application of asymmetric-flow field-flow (AF4) technology in fractionation and characterization of exosome subpopulations and novel nanoveiscles in pancreatic cancer model$70,783
R01 · FY2018 · CA
Development and application of asymmetric-flow field-flow (AF4) technology in fractionation and characterization of exosome subpopulations and novel nanoveiscles in pancreatic cancer model$472,052
R01 · FY2017 · CA